Fund BasicsSee More
- Fund Family Global X Mgt
- Assets Under Management 72,286,000
- Shares Outstanding, K 4,700
- 60-Month Beta 1.87
- Price/Earnings ttm -1.63
- Annual Dividend & Yield 0.54
- Most Recent Dividend 0.145
- Management Fee 0.50%
|Period||Period Low||Period High||Performance|
| || |
+4.28 (+38.35%)since 12/15/20
| || |
+7.34 (+90.62%)since 10/15/20
| || |
-1.46 (-8.64%)since 01/15/20
We have highlighted a pack of ETFs that are poised to outperform in 2021.
The start of the year 2021 has been great for global stocks with most of the indices enjoying a boom. Last week was no exception.
Democrats taking control of both House and Senate and the OPEC output cut deal coming in favorable for markets, these ETFs should stay strong in January.
Cannabis stocks and ETFs jumped following the Democratic victories in Georgia's two runoff elections that have spurred hopes for near-term decriminalization.
The U.S. market was in great shape as 2020 came to a close thanks mainly to massive global policy easing and vaccine rollouts.
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Given the prospect of loosening regulations and increased legalization, cannabis stocks are set to soar in 2021.
The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.
Last week was upbeat for Wall Street as vaccine hopes strengthened and consumers indulged in holiday shopping.
Thematic ETFs benefit from long-term, disruptive trends.
|3rd Resistance Point||17.88|
|2nd Resistance Point||17.27|
|1st Resistance Point||16.36|
|1st Support Level||14.84|
|2nd Support Level||14.23|
|3rd Support Level||13.32|